Regeneron Pharmaceuticals

777 Old Saw Mill River Rd Ste 10 , Tarrytown, NY 10591

Public
Healthcare & Pharmaceuticals - Biotechnology
over $1B
over 10K
(914) 847-7000


Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company's segment includes activities related to the discovery, development and commercialization of pharmaceutical products for the treatment of serious medical conditions. It commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol and a rare inflammatory condition, and has product candidates in development in other areas of unmet medical need, including oncology, rheumatoid arthritis (RA), asthma, atopic dermatitis, pain and infectious diseases. Its marketed products include EYLEA (aflibercept) injection, Praluent (alirocumab) Injection and ARCALYST (rilonacept) in... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with Regeneron Pharmaceuticals?


285 Contacts at this company
Hasan Wahdani
Sr. Project Manager
Michelle LaFond
Senior Director, Bioreactor Scale-Up and ...
Elisa Babilonia
Director
Linda Williams, RPh
Senior Manager
Kenneth Mahar
IOPS Systems Manager
David Hauss
Senior Director
Scott Walsh
Sales Associate
Liette Lecours, CQA
Associate Manager, IT Quality, QA ...
Eileen Gallagher
Manager, Site Start Up

Aug 6, 2018 17:30:50
CAMBRIDGE, Mass. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) [...]

Aug 6, 2018 17:06:30
CAMBRIDGE, Mass. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) [...]

Feb 13, 2018 06:53:54
TARRYTOWN, N.Y., Feb. 12, 2018 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced the appointment of Marion McCourt as the Senior Vice President and Head of Commercial. Ms. [...]

Oct 11, 2017 21:37:06
TARRYTOWN, N.Y., Oct. 11, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2017 financial and operating results on Wednesday, November [...]

Oct 2, 2017 20:13:12
TARRYTOWN, N.Y., Oct. 2, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced two new collaborations with the Biomedical Advanced Research and Development Authority (BARDA), part of the [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.